Legal & General Group’s Fortress Biotech FBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding FBIO
NCM
TCM
OM
OMC
SAM
PCM
CL
Legal & General Group's FBIO Position: Q3 2022 in Review
Legal & General Group sold out of Fortress Biotech (FBIO) in Q3 2022, closing a stake of 387 shares — an estimated $5K sold.
Legal & General Group first reported a position in FBIO in Q4 2016 and held it in 20 quarters. The position peaked at $141K in Q4 2020. 64 funds tracked by Wall St. Rank hold FBIO as of Q3 2022.
- Legal & General Group reported no remaining Fortress Biotech position as of Q3 2022 after selling out during the quarter.
- Legal & General Group sold 387 Fortress Biotech shares in Q3 2022, an estimated $5K.
- Legal & General Group first reported a position in Fortress Biotech in Q4 2016 and held it in 20 quarters.
- Legal & General Group's Fortress Biotech position peaked at $141K in Q4 2020.
- 64 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2022.
Based on Legal & General Group's 13F filing for Q3 2022, filed 14 Nov 2022.